![](https://engineering.jhu.edu/magazine/wp-content/uploads/2021/01/shutterstock_185401712-BW.jpeg)
Upstarts: A One-Two Punch for Tumors
Associate Professor Honggang Cui is leading a team in developing a dual chemo-immunotherapy treatment that is designed to create an immune-responsive environment through targeted, sustained release of a cancer immunotherapy drug.